Tissue-plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease
- 31 May 1995
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 115 (1) , 35-43
- https://doi.org/10.1016/0021-9150(94)05498-8
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Fibrinolytic activity and arterial diseaseThe Lancet, 1994
- Prospective study of endogenous tissue plasminogen activator and risk of strokeThe Lancet, 1994
- A cross-sectional study of endogenous tissue plasminogen activator, total cholesterol, HDL cholesterol, and apolipoproteins A-I, A-II, and B-100.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart StudyThe Lancet, 1993
- Insulin resistance and cigarette smokingThe Lancet, 1992
- Plasminogen Activator Inhibitor Type 1: Biochemistry and Evidence for Modulation of Fibrinolysis In VivoSeminars in Thrombosis and Hemostasis, 1992
- Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor.The Journal of Experimental Medicine, 1986
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- Ethyl alcohol enhances plasminogen activator secretion by endothelial cellsJAMA, 1983
- Coronary Heart Disease Incidence and Cardiovascular Mortality in Busselton with Reference to Glucose and Insulin ConcentrationsDiabetes Care, 1979